11 – 16 May 2019, Montreal, Canada
EMPIR project Innovative measurements for improved diagnosis and management of neurodegenerative diseases (15HLT04, NeuroMet) is developing non-invasive techniques for early diagnosis and monitoring of the progression of diseases such as Alzheimer’s and Parkinson’s. The research is exploring innovative techniques for early diagnosis and monitoring, based on non-invasive magnetic resonance imaging approaches. It is developing improved clinical assessment protocols focused on monitoring declining motor and cognitive functions and increasing behavioural, communicative and psychological symptoms.
Preliminary results were presented at the major 2018 ISMRM conference in Paris, and it is intended that additional results from the project will be presented at the 2019 ISMRM 27th Annual Meeting & Exhibition. The International Society for Magnetic Resonance in Medicine is a professional association dedicated to promoting communication, research, development and application of magnetic resonance techniques in medicine and biology.
For registration and further information visit https://www.ismrm.org/19m/
This EMPIR project is co-funded by the European Union's Horizon 2020 research and innovation programme and the EMPIR Participating States.
Want to hear more about EURAMET?
Sign up for EURAMET newsletters and other information
(You can select which information you would like to receive)
Better time synchronisation enables improved service for mobile customers more
Company licences two patent applications; best practice guide available more
30 – 31 May 2019, INRIM, Torino, Italy more
MeterEMI project newsletter available for download more
Presentation on force lever systems for wind turbines wins at IMEKO World Congress more